Tilray Brands Expands UK Medical Cannabis Market Through Lyphe Acquisition
The UK medical cannabis market consolidation is advancing with Tilray's acquisition of Lyphe Group. This move impacts treatment continuity and patient access. Understanding these changes is crucial for clinicians and patients alike.
Virginia Lawmakers Push Back on Governor’s Cannabis Amendments (Newsletter: April 15, 2026)
Virginia cannabis regulation updates are creating uncertainty for patient access to medical cannabis. Lawmakers are pushing back on gubernatorial amendments, impacting clinical practice. These regulation updates highlight the need for clinicians to…
Marijuana attitude a factor in Otoe County sentencing – Central – News Channel Nebraska
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Legal BarriersPatient AccessMedical…
The cannabis oligopoly flourishes while potential social equity licensees hemorrhage money
Cannabis social equity licensing barriers are limiting patient access to cannabis medicine by reducing dispensary locations and competition. Market consolidation driven by these barriers can increase costs and reduce product diversity. Patients and…
Commercial Insurance Has Failed Cannabis. Here’s What’s Next
Cannabis insurance coverage gaps create significant barriers to patient access and standardized care delivery. Without traditional insurance pathways, patients face unpredictable costs. This article explores the challenges and what’s next for cannabis…
A letter to the Croton Planning Board opposing approval of a cannabis dispensary in the village.
Community opposition medical cannabis often stems from stigma and misinformation affecting patient access. Understanding these barriers helps clinicians support their patients better. This article discusses local resistance to cannabis dispensaries and…